BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mammi C, Marzolla V, Armani A, Feraco A, Antelmi A, Maslak E, Chlopicki S, Cinti F, Hunt H, Fabbri A, Caprio M. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet. Int J Obes (Lond) 2016;40:964-72. [PMID: 26830012 DOI: 10.1038/ijo.2016.13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Cinti F, Cinti S. The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19. Cells 2022;11:2109. [DOI: 10.3390/cells11132109] [Reference Citation Analysis]
2 Nguyen ET, Berman S, Streicher J, Estrada CM, Caldwell JL, Ghisays V, Ulrich-Lai Y, Solomon MB. Effects of combined glucocorticoid/mineralocorticoid receptor modulation (CORT118335) on energy balance, adiposity, and lipid metabolism in male rats. Am J Physiol Endocrinol Metab 2019;317:E337-49. [PMID: 31112405 DOI: 10.1152/ajpendo.00018.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 McGowan SE, McCoy DM. Glucocorticoids Retain Bipotent Fibroblast Progenitors during Alveolar Septation in Mice. Am J Respir Cell Mol Biol 2017;57:111-20. [PMID: 28530121 DOI: 10.1165/rcmb.2016-0376OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
4 Li S, Miao Z, Tian Y, Wang H, Wang S, He T, Yang Y, Wang P, Ma M, Yang T, Chen T, Liu Z, Gao J, Chen C, Qian A. Limethason reduces airway inflammation in a murine model of ovalbumin-induced chronic asthma without causing side effects. Exp Ther Med 2018;15:2269-76. [PMID: 29456634 DOI: 10.3892/etm.2018.5691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ahmed RG. Gestational dexamethasone alters fetal neuroendocrine axis. Toxicol Lett 2016;258:46-54. [PMID: 27220267 DOI: 10.1016/j.toxlet.2016.05.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
6 Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of Adrenal Steroids on Regulation of Adipose Tissue. Compr Physiol 2017;7:1425-47. [PMID: 28915330 DOI: 10.1002/cphy.c160037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
7 Ribeiro RS, Passos CS, Novaes AS, Maquigussa E, Glória MA, Visoná I, Ykuta O, Oyama LM, Boim MA. Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice. PLoS One 2017;12:e0174721. [PMID: 28358868 DOI: 10.1371/journal.pone.0174721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Feraco A, Marzolla V, Scuteri A, Armani A, Caprio M. Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease. Trends Endocrinol Metab 2020;31:205-17. [PMID: 31843490 DOI: 10.1016/j.tem.2019.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
9 Ferreira GN, Rossi-valentim R, Buzelle SL, Paula-gomes S, Zanon NM, Garófalo MAR, Frasson D, Navegantes LCC, Chaves VE, Kettelhut IDC. Differential regulation of glyceroneogenesis by glucocorticoids in epididymal and retroperitoneal white adipose tissue from rats. Endocrine 2017;57:287-97. [DOI: 10.1007/s12020-017-1315-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Infante M, Armani A, Marzolla V, Fabbri A, Caprio M. Adipocyte Mineralocorticoid Receptor. Aldosterone. Elsevier; 2019. pp. 189-209. [DOI: 10.1016/bs.vh.2018.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Guerrero-García JJ, Carrera-Quintanar L, López-Roa RI, Márquez-Aguirre AL, Rojas-Mayorquín AE, Ortuño-Sahagún D. Multiple Sclerosis and Obesity: Possible Roles of Adipokines. Mediators Inflamm 2016;2016:4036232. [PMID: 27721574 DOI: 10.1155/2016/4036232] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
12 Ruiz-Ojeda FJ, Rupérez AI, Gomez-Llorente C, Gil A, Aguilera CM. Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A Review. Int J Mol Sci 2016;17:E1040. [PMID: 27376273 DOI: 10.3390/ijms17071040] [Cited by in Crossref: 152] [Cited by in F6Publishing: 139] [Article Influence: 25.3] [Reference Citation Analysis]
13 Bell RMB, Villalobos E, Nixon M, Miguelez-Crespo A, Murphy L, Fawkes A, Coutts A, Sharp MGF, Koerner MV, Allan E, Meijer OC, Houtman R, Odermatt A, Beck KR, Denham SG, Lee P, Homer NZM, Walker BR, Morgan RA. Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice. Mol Metab 2021;48:101225. [PMID: 33785425 DOI: 10.1016/j.molmet.2021.101225] [Reference Citation Analysis]
14 Meijer OC, Koorneef LL, Kroon J. Glucocorticoid receptor modulators. Ann Endocrinol (Paris) 2018;79:107-11. [PMID: 29731108 DOI: 10.1016/j.ando.2018.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
15 Kach J, Long TM, Selman P, Tonsing-Carter EY, Bacalao MA, Lastra RR, de Wet L, Comiskey S, Gillard M, VanOpstall C, West DC, Chan WC, Griend DV, Conzen SD, Szmulewitz RZ. Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth. Mol Cancer Ther 2017;16:1680-92. [PMID: 28428441 DOI: 10.1158/1535-7163.MCT-16-0923] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
16 Parker JC, Moraitis AG, Belanoff JK. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. AACE Clinical Case Reports 2022;8:25-9. [DOI: 10.1016/j.aace.2021.07.001] [Reference Citation Analysis]
17 Kroon J, Koorneef LL, van den Heuvel JK, Verzijl CRC, van de Velde NM, Mol IM, Sips HCM, Hunt H, Rensen PCN, Meijer OC. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice. Endocrinology 2018;159:535-46. [PMID: 28938459 DOI: 10.1210/en.2017-00512] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
18 De Nicola AF, Meyer M, Guennoun R, Schumacher M, Hunt H, Belanoff J, de Kloet ER, Gonzalez Deniselle MC. Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases. Int J Mol Sci 2020;21:E2137. [PMID: 32244957 DOI: 10.3390/ijms21062137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Do TTH, Marie G, Héloïse D, Guillaume D, Marthe M, Bruno F, Marion B. Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration. J Steroid Biochem Mol Biol 2019;185:150-62. [PMID: 30145227 DOI: 10.1016/j.jsbmb.2018.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Cataldi M, Citro V, Resnati C, Manco F, Tarantino G. New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants. Adv Ther 2021;38:2094-113. [PMID: 33761100 DOI: 10.1007/s12325-021-01669-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]